LensAge to Reveal Biological Age

October 19, 2022 updated by: Haotian Lin, Sun Yat-sen University

A Deep Learning-based Indicator to Reveal Biological Age Using Lens Photographs

Assessment of aging is central to health management. Compared to chronological age, biological age can better reflect the aging process and health status; however, an effective indicator of biological age in clinical practice is lacking. Human lens accumulates biological changes during aging and is amenable to a rapid and objective assessment. Therefore, the investigators will develop LensAge as an innovative indicator to reveal biological age based on deep learning using lens photographs.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

6000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Haotian Lin, M.D., Ph.D.
  • Phone Number: +86-020-87330274
  • Email: gddlht@aliyun.com

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510060
        • Recruiting
        • Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 98 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants aged 20 to 90 have anterior segment photographs, baseline information, and medical records.

Description

Inclusion Criteria:

  • ages from 20 to 100 years
  • have anterior segment photographs
  • have ophthalmic and physical examination records

Exclusion Criteria:

  • have a history of previous eye surgery, eye trauma, or ocular diseases that can cause complicated cataracts
  • baseline information missing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Aging group
Participants with baseline information, medical history of diseases, and lens photographs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The difference between LensAge and chronological age
Time Frame: Baseline
The age estimation models based on a convolutional neural network (CNN) using lens photographs will be used to generate LensAge. LensAge at the individual level will be calculated by averaging the results of all images corresponding to one individual. The difference between LensAge at the individual level and chronological age will be used to unveil an individual's aging process. A difference above 0 indicates an individual with a faster pace of aging than their peers of the same chronological age, while a difference below 0 indicates a slower pace of aging.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the LensAge difference and age-related health parameters
Time Frame: Baseline
Age-corrected LensAge differences will be used to investigate the odds ratios (ORs) with age-related health parameters.
Baseline
Mean absolute error (MAE) of the DL age estimation model.
Time Frame: Baseline
Mean absolute error (MAE) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
Baseline
Mean error (ME) of the DL age estimation model.
Time Frame: Baseline
Mean error (ME) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
Baseline
R-squared (R2) of the DL age estimation model.
Time Frame: Baseline
R-squared (R2) in terms of both image level and individual level will be used to evaluate the performance of the DL age estimation model.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Haotian Lin, M.D., Ph.D., Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Anticipated)

December 30, 2022

Study Completion (Anticipated)

December 30, 2022

Study Registration Dates

First Submitted

October 17, 2022

First Submitted That Met QC Criteria

October 17, 2022

First Posted (Actual)

October 20, 2022

Study Record Updates

Last Update Posted (Actual)

October 21, 2022

Last Update Submitted That Met QC Criteria

October 19, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LA-2022

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lens Opacities

3
Subscribe